Missing/wrong data?
Log in to edit
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
scientific article published on 19 September 2016
Author/s
author: Eva Segelov, David Kerr, Enric Domingo, Ian Tomlinson, Peter Hewett, Elaine C Johnstone, Francesco Pezzella
Work details
Publication date
September 19, 2016
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.